Computational Biology Market Is Predicted To Reach USD 4,285.1 Million By 2020: By Grand View Research, Inc.
The Global computational biology market is expected to reach
USD 4,285.1 million by 2020 growing at a CAGR of 21.1%, according to a new
study by Grand View Research, Inc. Steady increase in the usage &
application of computational biology for bioinformatics R&D programs designed
for sequencing genomes to better understand biological systems and increasing
number of clinical studies in pharmacogenomics and pharmacokinetics for novel
drug discovery studies are expected to drive computational biology demand over
the next six years.
Computational genomics for
cellular and biological simulation applications dominated the market in 2013,
accounting for over 47% of global revenue. Key factors driving demand for these
applications include the growth of drug designing, disease modeling and personalized
medicine applications and the growing usage of computational biology for
functional and structural genomics, epigenomics and metagenomics for the
analysis of protein transcription, protein-protein interactions, gene
sequencing and expression and 3-dimensional protein structure analysis.
Browse full research
report on Computational Biology Market: http://www.grandviewresearch.com/industry-analysis/computational-biology-market
Further key findings from the study suggest:
- North America
was the largest regional market, accounting for 58.0% of the global
revenue in 2013. Its large share is majorly attributed to the growing
research investments and initiatives for development of drug discovery,
disease modeling technologies and innovations in biological computation
methods. It is expected that Asia Pacific will witness the fastest growth
in the market, at an estimated CAGR of 28.0% owing to the increasing
expenditure in clinical studies for pharmacokinetics and pharmacogenomics.
- The
application of computational biology in proteomics for cellular simulation
is expected to grow at the fastest CAGR of over 22% owing to the shift in
sequencing studies towards further analysis of the nature of various
biological proteins as a part of development of personalized medicine.
- Drug
discovery and disease modelling applications dominated the market,
accounting for 58.0% of global revenue in 2013. This large share is
attributed by the extensive drug development pipelines present for a
number of global branded and generic drug manufacturing firms such as
Sanofi, Novo Nordisk and Eli Lilly.
- Computational
Biology databases dominated the tools segment and accounted for 44.5% of
the market revenue in 2013, owing to extensive genomic database usage for
warehousing and data mining of biological and sequential data generated
from genomic and proteomic studies. Consequentially, the software and
services for the analysis of biological data is expected to witness the
fastest CAGR of over 21.0%.
- Key players
of this market include Schrodinger, Accelrys, Certara, Entelos, Simulation
Plus and others.
Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-computational-biology-market
About Grand View Research,
Inc:
Grand View Research, Inc. is a U.S. based market research and consulting
company, registered in the State of California and headquartered in San
Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
For more information: http://www.grandviewresearch.com
Comments
Post a Comment